Freedom Capital Markets Initiates Coverage On Inspire Medical Systems with Buy Rating, Announces Price Target of $62
Freedom Capital Markets analyst Keith Hinton initiates coverage on Inspire Medical Systems (NYSE: INSP ) with a Buy rating and announces Price Target of $62.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.